SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Intellia Therapeutics Q1 EPS $(0.630) Misses $(0.440) Estimate, Sales $12.916M Miss $18.140M Estimate

Intellia Therapeutics (NASDAQ:NTLA) reported quarterly losses of $(0.630) per share which missed the analyst consensus estimate of $(0.440) by 43.18 percent. This is a 28.57 percent decrease over losses of $(0.490) per

Benzinga · 05/07/2020 12:13

Intellia Therapeutics (NASDAQ:NTLA) reported quarterly losses of $(0.630) per share which missed the analyst consensus estimate of $(0.440) by 43.18 percent. This is a 28.57 percent decrease over losses of $(0.490) per share from the same period last year. The company reported quarterly sales of $12.916 million which missed the analyst consensus estimate of $18.140 million by 28.80 percent. This is a 23.80 percent increase over sales of $10.433 million the same period last year.